Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.20
Bid: 49.90
Ask: 50.20
Change: 1.60 (3.29%)
Spread: 0.30 (0.601%)
Open: 48.45
High: 51.10
Low: 47.20
Prev. Close: 48.60
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

13 Jan 2022 18:06

RNS Number : 4114Y
IP Group PLC
13 January 2022
 

IP GROUP plc (the "Company")

 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 8 October 2021 (the Buyback Programme).

Date of purchase:

13-Jan-22

Number of ordinary shares purchased:

300,000

Highest price paid per ordinary share (GBp):

116.00

Lowest price paid per ordinary share (GBp):

112.80

Volume weighted average price paid per ordinary share (GBp):

114.3542

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 24,989,127 of its ordinary shares in treasury and has 1,063,033,287 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,038,044,160, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Numis Securities Limited on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

13 January 2022

Number of ordinary shares purchased:

300,000

Volume weighted average price (pence):

114.3542

Individual transactions:

 

Number of sharespurchased

Transaction price(per share)

Time of transaction

Trading venue

781

114.40

 08:36:33

LSE

3363

114.40

 08:36:33

LSE

2532

114.40

 08:37:00

LSE

369

114.20

 08:37:11

LSE

6185

114.20

 08:38:00

LSE

6821

114.20

 08:38:00

LSE

365

115.80

 08:55:56

LSE

6654

115.80

 08:55:56

LSE

6405

115.60

 08:55:57

LSE

6980

115.40

 09:17:54

LSE

6448

115.00

 09:18:00

LSE

1292

115.60

 09:34:58

LSE

5718

115.60

 09:34:58

LSE

3258

115.60

 09:42:35

LSE

1492

116.00

 10:29:38

LSE

7109

115.80

 10:44:34

LSE

6877

115.20

 10:58:43

LSE

6827

115.80

 11:52:44

LSE

6695

115.80

 11:52:44

LSE

7353

115.40

 12:09:28

LSE

6867

116.00

 12:41:31

LSE

2022

116.00

 13:30:13

LSE

2100

116.00

 13:30:13

LSE

2553

116.00

 13:30:13

LSE

246

115.80

 13:35:00

LSE

7073

115.80

 13:35:00

LSE

5300

115.40

 13:44:42

LSE

1661

115.40

 13:44:42

LSE

715

115.40

 14:15:17

LSE

1197

115.40

 14:19:39

LSE

2100

115.40

 14:19:39

LSE

1974

115.40

 14:19:39

LSE

1057

115.40

 14:19:39

LSE

290

115.00

 14:35:57

LSE

1277

115.00

 14:36:12

LSE

4420

115.00

 14:36:12

LSE

1662

114.60

 14:59:22

LSE

2100

114.60

 14:59:22

LSE

2100

114.60

 14:59:22

LSE

485

114.60

 14:59:22

LSE

1514

114.40

 15:03:10

LSE

1646

114.40

 15:03:10

LSE

2100

114.40

 15:03:10

LSE

2100

114.40

 15:03:10

LSE

10203

114.20

 15:12:45

LSE

84

114.20

 15:12:45

LSE

4633

114.00

 15:19:20

LSE

2459

114.00

 15:19:20

LSE

4608

113.60

 15:31:27

LSE

2289

113.60

 15:31:27

LSE

7085

113.20

 15:39:41

LSE

6990

112.80

 15:42:06

LSE

2098

113.40

 15:52:20

LSE

362

113.40

 15:52:20

LSE

3450

113.40

 15:52:20

LSE

543

113.40

 15:52:27

LSE

1200

113.40

 15:52:27

LSE

6039

113.60

 16:06:38

LSE

6186

113.60

 16:06:38

LSE

4392

113.60

 16:06:38

LSE

2910

113.60

 16:06:38

LSE

37682

113.40

 16:06:38

LSE

4000

113.40

 16:06:38

LSE

1887

113.40

 16:06:38

LSE

632

113.40

 16:06:38

LSE

127

113.40

 16:06:38

LSE

1511

113.40

 16:06:38

LSE

249

113.40

 16:06:39

LSE

3912

113.40

 16:06:40

LSE

410

113.20

 16:11:43

LSE

937

113.20

 16:14:13

LSE

750

113.20

 16:14:48

LSE

1298

113.20

 16:15:03

LSE

1363

113.20

 16:15:13

LSE

991

113.20

 16:15:58

LSE

1507

113.20

 16:16:28

LSE

1298

113.20

 16:16:43

LSE

441

113.20

 16:17:13

LSE

253

113.20

 16:17:28

LSE

908

113.20

 16:17:38

LSE

996

113.20

 16:18:02

LSE

1129

113.20

 16:18:23

LSE

410

113.20

 16:19:21

LSE

523

113.20

 16:19:21

LSE

340

113.20

 16:19:21

LSE

1446

113.20

 16:19:21

LSE

6510

113.20

 16:19:21

LSE

6206

113.20

 16:19:21

LSE

3989

113.20

 16:19:22

LSE

1359

113.00

 16:21:43

LSE

2510

113.40

 16:27:14

LSE

812

113.40

 16:27:14

LSE

 

 

 

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGMMRFKGZZM
Date   Source Headline
28th May 202110:00 amRNSJoint venture with China Everbright to launch fund
27th May 20217:00 amRNSPortfolio co Pulmocide completes $92m Series C
26th May 20212:44 pmRNSUpdate on AGM
20th May 202110:01 amRNSScrip Dividend Reference Price
17th May 202112:44 pmRNSAdditional fair value gain of £20m
12th May 202112:08 pmRNSHolding(s) in Company
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 20207:00 amRNSEnterprise Therapeutics' program acquired by Roche
23rd Sep 20201:40 pmRNSHolding(s) in Company
15th Sep 202012:07 pmRNSSecond Price Monitoring Extn
15th Sep 202012:02 pmRNSPrice Monitoring Extension
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20205:18 pmRNSForm 8.3 - Modern Water plc
5th Aug 20207:00 amRNSHalf-yearly results
3rd Aug 20207:00 amRNSNanopore partners with govt on covid-19 test
30th Jul 202012:08 pmRNSSecond Price Monitoring Extn
30th Jul 202012:02 pmRNSPrice Monitoring Extension
29th Jul 20209:45 amRNSHolding(s) in Company
28th Jul 20202:44 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.